T2 Biosystems, Inc. 8-K Filing: Key Corporate Updates & Stock Info

Based on the provided excerpt from the financial report, here are the key insights:
- Entity Information:
- Company Name: T2 Biosystems, Inc.
- CIK: 0001492674
- State of Incorporation: Delaware (DE)
- SEC File Number: 001-36571
- EIN: 20-4827488
- Address: 101 Hartwell Avenue, Lexington, MA 02421
- Phone Number: 781-761-4646
- Filing Type and Date:
- Filing Type: 8-K (Current Report)
- Filing Date: February 13, 2025
- Stock Information:
- Type of Security: Common stock
- Par Value: $0.001 per share
- Context Information:
- The report covers a specific period that begins and ends on February 13, 2025.
- Miscellaneous:
- The XML structure indicates this is part of an XBRL (eXtensible Business Reporting Language) filing, commonly used for regulatory reporting.
Summary:
This section outlines an 8-K filing by T2 Biosystems, Inc., providing essential corporate information such as the company’s identification, filing details, and stock information. The report is set for a specific date in 2025, suggesting it may contain significant updates or disclosures pertinent to investors or regulators.